No one should die of Tuberculosis.
Tuberculosis is the leading infectious disease, and Sierra Leone has one of the highest rates of mortality from Tuberculosis globally. With your support, we can help ensure that another adult and child does not die from a preventable and curable disease.
Together, we can stop TB
Our Partners In Health Engage network aims to connect with 4,500 donors to raise $ 130,000 this year to support PIH TB programming. With your sustained attention and support, we aim to assist PIH in supplying comprehensive 4-month treatment courses for TB or 6-month treatment courses for MDR-TB for adults and children.
Your donations will also support in X-rays screening and laboratory tests to diagnose TB, along with monthly nutritional support.
Tuberculosis: A disease of injustice
- In 2023 alone, over 10.8 million people fell ill with tuberculosis, and 1.25 million people died from this preventable disease. Over 87% of these cases and deaths occur in low and middle-income countries.
- Tuberculosis transmission and progression are largely driven by social factors such as poor living conditions and poor nutrition
"Tuberculosis is as old as humanity itself. It has afflicted kings and queens, poets and politicians, revolutionaries and writers, activists and actors. Most of its victims, however, are poor, marginalised or malnourished, and the out-of-pocket costs associated with treating TB expose them to financial hardship or drive them further into poverty. TB is the definitive disease of deprivation. Turning the tide on TB means screening and treatment for those it strikes, and preventing it by addressing its drivers and developing a new vaccine. Only by working together can we turn the tide against this ancient killer."
- Dr. Tedros Adhanom Ghebreyesus (World Health Organization)
Help ensure TB care is accessible!
Sierra Leone is one of 30 countries with the highest burden of TB globally, but each year, many cases are missed. Until 2022, the Lakka government hospital had the country’s first and only multidrug-resistant tuberculosis (MDR-TB) treatment program. Following, a treatment center for drug-resistant tuberculosis (DR-TB) opened at Koidu Government Hospital (KGH) to decentralize care.
To address Tuberculosis care, PIH-SL introduced community-based interventions for TB screening. Community interventions like screening with portable X-ray machines, contact tracing through CHWs, and expanding the use of the GeneXpert, a machine that quickly tests clinical samples, are contributing to the increase of notified patients who can now receive care.
